Nalmefene
Revex, Selincro (nalmefene) is a small molecule pharmaceutical. Nalmefene was first approved as Revex on 1995-04-17. It is used to treat drug overdose, opioid-related disorders, and respiration disorders in the USA. It has been approved in Europe to treat alcohol-related disorders. The pharmaceutical is active against mu-type opioid receptor and kappa-type opioid receptor. In addition, it is known to target delta-type opioid receptor.
Trade Name | Selincro |
---|---|
Common Name | Nalmefene |
Indication | alcohol-related disorders, drug overdose, opioid-related disorders, respiration disorders |
Drug Class | Narcotic agonists/antagonists (normorphine type) |